Clinical Trial Detail

NCT ID NCT03695380
Title A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

endometrioid ovary carcinoma

ovarian serous carcinoma

fallopian tube cancer

peritoneum cancer

Therapies

Atezolizumab + Cobimetinib + Niraparib

Cobimetinib + Niraparib

Age Groups: adult senior

No variant requirements are available.